Compare Eli Lilly And Co (LLY) vs Advanced Drainage Systems Inc (WMS) Price & Performance

Eli Lilly (LLY) trades at $1,169.93, down 1.58% on the day, but maintains strong bullish momentum with consistent earnings beats and robust revenue growth. The company's weight-loss drug portfolio continues to drive exceptional performance, with Q2 2026 EPS of $8.38 beating expectations by 31%. Technical indicators show bullish moving averages while fundamentals reveal impressive 83.4% gross margins and 102.44% ROE. Recent clinical trial successes for next-generation obesity treatments position Lilly for continued market leadership.

LLY presents a compelling growth story with dominant positioning in the expanding obesity/diabetes market, though elevated valuations (P/E 39.26) and regulatory risks require monitoring. Analyst consensus remains strongly bullish with $1,350 price target representing 15% upside. The primary investment thesis centers on pipeline execution and market expansion opportunities, balanced against competitive pressures and valuation concerns.

Advanced Drainage Systems (WMS) trades at $126.21, up 0.1% with a bearish technical signal. The company shows strong profitability with 14% net margins and 24.9% ROE, though recent earnings beat expectations. Revenue remains stable around $2.9B with solid cash flow generation. Institutional activity shows mixed sentiment with major players like BlackRock increasing positions while others reduced stakes.

WMS presents a compelling value opportunity with analyst consensus target of $188.20 (49% upside) despite near-term technical weakness. Strong fundamentals and market leadership in water management support long-term growth, though investors face risks from cyclical construction demand and elevated valuation multiples relative to historical levels.